Clinical Trials Directory

Trials / Unknown

UnknownNCT01626911

Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Nanjing University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Our animal studies found that continuous regional arterial infusion (CRAI in the celiac trunk) of low molecular weight heparin (LMWH) could alleviate inflammation, improve global hemodynamics and restore organ function in a porcine model of severe acute pancreatitis (SAP,unpublished). In this study, the investigators aim to evaluate the effects of CRAI of LMWH in the treatment of SAP patients. The investigators suppose CRAI could help improve the outcomes of these patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREContinuous regional arterial infusion of low molecular weight heparin in celiac trunkPut a catheter to the celiac trunk through interventional technique. The approach to celiac trunk was via a femoral artery approach.The tip of the arterial catheter (4F) was placed in celiac trunk which could perfuse the pancreas.After that, continuous infusion of low molecular weight heparin through the catheter will be applied during the first 5 days after placement.
OTHERGeneral treatmentInclude fluid resuscitation, percutaneous drainage if needed, antibiotics,organ support, etc.

Timeline

Start date
2011-09-01
Primary completion
2013-12-01
First posted
2012-06-25
Last updated
2013-12-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01626911. Inclusion in this directory is not an endorsement.